aXichem AB

Research aXichem AB (AXIC-A) on Bullrun: market cap SEK 181.51M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 181.51M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 18.45M-SEK 17.63M-SEK 11.35M49.2%-0.3SEK 3.08MSEK 4.73MSEK 52.86M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-27SEK 181.51Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About aXichem AB

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen, a solution for improved health for chickens, hens, pigs, and piglets.

Related stock research

Other Basic Materials stocks

Frequently asked questions

What is aXichem AB's market cap?

aXichem AB's market capitalization is SEK 181.51M.

What does aXichem AB do?

aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. The company offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen, a solution for improved health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.